• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将被困离子淌度谱与液相色谱和串联质谱联用分析 PDE-5 抑制剂类似物的异构体。

Combining trapped ion mobility spectrometry with liquid chromatography and tandem mass spectrometry for analysis of isomeric PDE-5 inhibitor analogs.

机构信息

US Food and Drug Administration, Office of Regulatory Affairs, Office of Regulatory Science, Forensic Chemistry Center, Cincinnati, OH, USA.

Bruker Daltonics & Co. KG, Solutions Development, Applied Markets & Characterization, Bremen, Germany.

出版信息

J Pharm Biomed Anal. 2023 Feb 20;225:115210. doi: 10.1016/j.jpba.2022.115210. Epub 2022 Dec 20.

DOI:10.1016/j.jpba.2022.115210
PMID:36586385
Abstract

The detection and identification of phosphodiesterase type 5 enzyme (PDE-5) inhibitors in dietary supplements poses an analytical challenge due to the large number of analogs and isomers currently available and the continued introduction of novel analogs. The use of trapped ion mobility spectrometry (TIMS) in conjunction with liquid chromatography (LC) and electrospray ionization tandem mass spectrometry (MS/MS) was explored for the analysis of two groups of isomeric PDE-5 inhibitor analogs using a 5-minute method. Of the eight compounds studied, six were resolved by a combination of LC and TIMS; the two remaining isomers were distinguished by one or more unique product ions in the MS/MS spectrum. The results revealed that separation by LC corresponded to differences in substitution on the piperazine moiety of the PDE-5 inhibitors, while separation by TIMS corresponded to the position of a nitrogen atom in the fused ring region of the molecules. Samples prepared by spiking mixtures of varying amounts of the Group 2 isomers into a representative dietary supplement matrix were analyzed and concentrations determined from the mobility-adjusted extracted ion chromatograms exhibited relative standard deviations of 6.0 % or less for 17 of 20 measurements and recoveries between 80 % and 120 % for all measurements. Quantitative measurements from a short LC gradient were possible due to the reduced chemical background associated with the TIMS separation of co-eluting matrix compounds, which enabled acquisition of rapid and qualitatively relevant broadband collision induced dissociation spectra that didn't require precursor ion isolation; the reduced chemical background permits non-targeted detection of novel analogs and eliminates the need for a separate method for quantitative measurement.

摘要

由于目前可用的类似物和异构体数量众多,并且新型类似物不断推出,因此检测和鉴定膳食补充剂中的磷酸二酯酶 5 型酶(PDE-5)抑制剂具有分析上的挑战。本文探讨了使用被困离子淌度谱(TIMS)结合液相色谱(LC)和电喷雾串联质谱(MS/MS)分析两组结构异构体 PDE-5 抑制剂类似物的方法,该方法采用 5 分钟的方法。在所研究的 8 种化合物中,有 6 种通过 LC 和 TIMS 的组合得到了分离;其余两种异构体通过 MS/MS 谱中的一个或多个独特产物离子来区分。结果表明,LC 的分离对应于 PDE-5 抑制剂中哌嗪部分取代基的差异,而 TIMS 的分离对应于分子的稠环区域中氮原子的位置。通过向代表性膳食补充剂基质中掺入不同量的第 2 组异构体混合物制备样品,并从经过淌度校正的提取离子色谱图中确定浓度,对于 20 次测量中的 17 次,其相对标准偏差小于 6.0%,所有测量的回收率在 80%至 120%之间。由于与 TIMS 分离共洗脱基质化合物相关的化学背景减少,因此可以进行短 LC 梯度的定量测量,这使得能够获得快速且具有定性相关性的宽带碰撞诱导解离谱,而无需进行前体离子的隔离;减少的化学背景允许对新型类似物进行非靶向检测,并消除了对定量测量的单独方法的需求。

相似文献

1
Combining trapped ion mobility spectrometry with liquid chromatography and tandem mass spectrometry for analysis of isomeric PDE-5 inhibitor analogs.将被困离子淌度谱与液相色谱和串联质谱联用分析 PDE-5 抑制剂类似物的异构体。
J Pharm Biomed Anal. 2023 Feb 20;225:115210. doi: 10.1016/j.jpba.2022.115210. Epub 2022 Dec 20.
2
Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.筛查合成 PDE-5 抑制剂及其类似物作为掺杂物:分析技术和挑战。
J Pharm Biomed Anal. 2014 Jan;87:176-90. doi: 10.1016/j.jpba.2013.04.037. Epub 2013 May 6.
3
[LC/Tribrid Orbitrap Analysis of Phosphodiesterase-5 Inhibitors and Their Analogs as Adulterants in Dietary Supplements].[液相色谱/三合一轨道阱分析磷酸二酯酶-5抑制剂及其类似物作为膳食补充剂中的掺假物]
Shokuhin Eiseigaku Zasshi. 2019;60(4):96-107. doi: 10.3358/shokueishi.60.96.
4
Probing Polyester Branching by Hybrid Trapped Ion-Mobility Spectrometry-Tandem Mass Spectrometry.利用混合囚禁离子淌度质谱-串联质谱技术探测聚酯支化。
J Am Soc Mass Spectrom. 2021 Jun 2;32(6):1498-1507. doi: 10.1021/jasms.1c00071. Epub 2021 May 14.
5
Hierarchical clustering of liquid chromatography-tandem mass spectrometry data for screening of phosphodiesterase type 5 inhibitors and their analogues in adulterated dietary supplements.基于液相色谱-串联质谱数据的层次聚类分析用于筛选掺假膳食补充剂中的磷酸二酯酶 5 抑制剂及其类似物。
J Chromatogr A. 2022 Aug 16;1678:463366. doi: 10.1016/j.chroma.2022.463366. Epub 2022 Jul 23.
6
Bottom-up Histone Post-translational Modification Analysis using Liquid Chromatography, Trapped Ion Mobility Spectrometry, and Tandem Mass Spectrometry.基于液相色谱、离子淌度谱和串联质谱的组蛋白翻译后修饰的自上而下分析。
J Proteome Res. 2024 Sep 6;23(9):3867-3876. doi: 10.1021/acs.jproteome.4c00177. Epub 2024 Aug 23.
7
Accurate Identification of Isomeric Glycans by Trapped Ion Mobility Spectrometry-Electronic Excitation Dissociation Tandem Mass Spectrometry.利用被困离子淌度质谱-电子激发解离串联质谱技术准确识别同分异构体聚糖。
Anal Chem. 2020 Oct 6;92(19):13211-13220. doi: 10.1021/acs.analchem.0c02374. Epub 2020 Sep 11.
8
Analysis of isomeric opioids in urine using LC-TIMS-TOF MS.采用 LC-TIMS-TOF MS 分析尿液中的同系物阿片类药物。
Talanta. 2018 Jun 1;183:177-183. doi: 10.1016/j.talanta.2018.02.077. Epub 2018 Feb 19.
9
Mobility-resolved broadband dissociation and parallel reaction monitoring for laser desorption/ionization-mass spectrometry - Tattoo pigment identification supported by trapped ion mobility spectrometry.用于激光解吸/电离质谱的迁移分辨宽带解离和平行反应监测——基于阱式离子迁移谱的纹身色素鉴定
Anal Chim Acta. 2023 Feb 15;1242:340796. doi: 10.1016/j.aca.2023.340796. Epub 2023 Jan 6.
10
A novel approach to simultaneous screening and confirmation of regulated pharmaceutical compounds in dietary supplements by LC/MS/MS with an information-dependent acquisition method.采用 LC/MS/MS 结合信息依赖性采集方法对膳食补充剂中的调节性药物化合物进行同时筛选和确证的新方法。
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2011 Apr;28(4):396-407. doi: 10.1080/19440049.2011.551947.